Skip to main content
. 2009 Jan 1;32(1):91–98.

Table 3.

Sleep Data at Baseline and 3 Months after Randomization According to CPAP-Response

Control group (n = 108)
CPAP-CSA-suppressed (n = 58)
CPAP-CSA-unsuppressed (n = 39)
Between group P-value
Baseline 3 months Baseline 3 months Baseline 3 months
Effect on CSA
    Total AHI, no/h 37.8 ± 15.1 37.6 ± 25.7 33.8 ± 12.7 6.2 ± 3.9 46.9 ± 14.9 34.6 ± 12.4 < 0.001*
Effect on Arousals
    Arousal index, no/h 24.8 ± 19.3 26.3 ± 18.6 24.0 ± 16.6 18.4 ± 15.5 36.4 ± 30.3 33.1 ± 21.5 0.15
Effect on Sleep Structure
    Time in bed, min 452.4 ± 51.4 457.5 ± 48.9 456.1 ± 52.2 450.8 ± 44.6 452.8 ± 51.8 464.3 ± 44.9 0.14
    Sleep period time, min 421.4 ± 52.7 423.7 ± 55.9 426.6 ± 57.3 420.9 ± 47.1 432.4 ± 50.3 432.0 ± 47.4 0.47
    Total sleep time, min 310.5 ± 84.3 308.9 ± 77.6 321.4 ± 77.0 326.1 ± 65.3 314.9 ± 74.7 309.9 ± 83.0 0.88
    Sleep efficiency, % 68.4 ± 16.5 67.8 ± 16.6 70.6 ± 16.2 72.4 ± 13.3 70.1 ± 16.9 67.3 ± 18.3 0.40
    Sleep onset latency, min 30.8 ± 30.8 33.7 ± 36.5 28.9 ± 31.0 29.7 ± 29.6 19.9 ± 21.1 32.0 ± 29.4 0.08
    Wake after sleep onset, min 111.0 ± 65.4 114.8 ± 70.0 105.3 ± 62.8 94.8 ± 51.5 117.4 ± 79.8 122.1 ± 80.1 0.36
    Stage 1 percentage, % 18.2 ± 12.8 18.9 ± 12.9 18.4 ± 12.0 15.2 ± 14.2 20.3 ± 15.5 18.8 ± 16.9 0.27
    Stage 2 percentage, % 58.8 ± 13.5 58.0 ± 14.4 55.8 ± 14.6 57.3 ± 14.8 57.8 ± 16.7 61.9 ± 16.1 0.20
    SWS percentage, % 9.6 ± 11.0 10.3 ± 10.8 11.4 ± 10.7 12.6 ± 12.2 9.8 ± 9.3 8.4 ± 10.4 0.37
    REM sleep percentage, % 13.1 ± 6.8 12.7 ± 7.9 14.4 ± 6.6 14.8 ± 6.3 12.3 ± 7.4 10.9 ± 7.3 0.45
    PLMI, no/h 25.8 ± 38.9 24.1 ± 33.2 22.2 ± 32.8 23.3 ± 28.5 29.8 ± 49.8 32.3 ± 50.4 0.37

Values are expressed as means ± SD.

Abbreviations: AHI = apnea-hypopnea index, CSA = central sleep apnea, PLMI = periodic leg movement index, SWS = slow wave sleep.

*

Compared the changes over time between; Control vs. CPAP responder P < 0.001, Control vs. CPAP non responder P = 0.01, CPAP responder vs. CPAP non responder P = 0.002.